Bibliographies thématiques / Metronomica

Sommaire

  1. Articles de revues
  2. Thèses
  3. Livres
  4. Chapitres de livres
  5. Actes de conférences
  6. Rapports d'organisations

Littérature scientifique sur le sujet « Metronomica »

Auteur : Grafiati
Publié le 9 mars 2023
Mis à jour le 31 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Metronomica ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Metronomica"

1

Orlandi, Armando, Elena Iattoni, Carmela Di Dio, and Maria Alessandra Calegari. "Efficacia duratura e ottima tollerabilità di lapatinib associato a capecitabina metronomica in due pazienti con carcinoma mammario HER2-positivo." AboutOpen 3, no. 1 (2017): 112–16. http://dx.doi.org/10.19156/abtpn.2017.0026.

Texte intégral
Résumé :
L’utilizzo di lapatinib in combinazione con capecitabina è associato in alcune pazienti a tossicità gastrointestinale e cutanea, che ne compromette la regolare assunzione limitando l’utilizzo di un’efficace schedula terapeutica nel carcinoma metastatico della mammella HER2-positivo, refrattario al trattamento con trastuzumab. I due casi clinici presentati mostrano il buon profilo di tossicità e l’efficacia della combinazione lapatinib (1250 mg/die) + capecitabina metronomica (500 mg 3 volte/die) (Oncology).
Styles APA, Harvard, Vancouver, ISO, etc.
2

Arvat, Emanuela. "Impiego della chemioterapia metronomica in pazienti con carcinoma surrenalico metastatico sottoposti a multipli trattamenti precedenti." L'Endocrinologo 15, no. 5 (2014): 240. http://dx.doi.org/10.1007/s40619-014-0074-1.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Revon-Rivière, Gabriel, Shripad Banavali, Laila Heississen, et al. "Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists." Journal of Global Oncology, no. 5 (December 2019): 1–8. http://dx.doi.org/10.1200/jgo.18.00244.

Texte intégral
Résumé :
PURPOSE Low- and middle-income countries (LMICs) experience the burden of 80% of new childhood cancer cases worldwide, with cure rates as low as 10% in some countries. Metronomics combines frequent administrations of low-dose chemotherapy with drug repurposing, which consists of using already-approved drugs for new medical applications. With wide availability, limited costs, and little infrastructure needs, metronomics can be part of constraint-adapted regimens in these resource-limited settings—with the understanding that metronomics shall not be a substitute for standard treatments when avai
Styles APA, Harvard, Vancouver, ISO, etc.
4

Svoboda, Tomáš. "Metronomic chemotherapy in breast cancer." Onkologie 10, no. 4 (2016): 161–65. http://dx.doi.org/10.36290/xon.2016.035.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Muraro, Elena, Lorenzo Vinante, Elisabetta Fratta, et al. "Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors." Cancers 15, no. 9 (2023): 2471. http://dx.doi.org/10.3390/cancers15092471.

Texte intégral
Résumé :
Increasing evidence pinpoints metronomic chemotherapy, a frequent and low dose drug administration with no prolonged drug-free intervals, as a potential tool to fight certain types of cancers. The primary identified targets of metronomic chemotherapy were the tumor endothelial cells involved in angiogenesis. After this, metronomic chemotherapy has been shown to efficiently target the heterogeneous population of tumor cells and, more importantly, elicit the innate and adaptive immune system reverting the “cold” to ”hot” tumor immunologic phenotype. Although metronomic chemotherapy is primarily
Styles APA, Harvard, Vancouver, ISO, etc.
6

Teixeira, N. C. T., A. P. C. V. Bicalho, A. V. Vasconcelos, R. S. Horta, R. M. C. Cunha, and G. E. Lavalle. "Ciclooxygenase inhibitor and metronomic chemotherapy association for the treatment of metastatic anal sac carcinoma in dog: case report." Arquivo Brasileiro de Medicina Veterinária e Zootecnia 68, no. 4 (2016): 913–18. http://dx.doi.org/10.1590/1678-4162-8439.

Texte intégral
Résumé :
ABSTRACT Metronomic chemotherapy consists of an anticancer modality treatment. It is applicable in patients at an advanced stage, with the objective of increasing overall survival. The aim of this study was to report an anal sac apocrine carcinoma case in a dog with lymph node metastasis treated with metronomic chemotherapy sequential to surgery and conventional chemotherapy using gemcitabine and carboplatin. Metronomic chemotherapy was associated with cyclooxygenase-2 (COX-2) inhibitors, due to strong tumor COX-2 immunohistochemistry expression. Metronomic chemotherapy was initiated with cycl
Styles APA, Harvard, Vancouver, ISO, etc.
7

Olovnikov, Alexey M. "Planetary Metronome as a Regulator of Lifespan and Aging Rate: The Metronomic Hypothesis." Biochemistry (Moscow) 87, no. 12-13 (2022): 1640–50. http://dx.doi.org/10.1134/s0006297922120197.

Texte intégral
Résumé :
Abstract A metronomic mechanism for the duration control of ontogenetic cycle periods of an animal is proposed. The components of the proposed metronomic system include the ventricular system of the brain, planet Earth as a generator of metronomic signals, and temporal DNA (tDNA) as a substrate that is epigenetically marked to measure elapsed time of ontogenesis. The metronomic system generates repetitive signals in the form of hydrodynamic disturbances in the cerebrospinal fluid (CSF). The metronomic effect arises due to the superposition of two processes – the near-wall unidirectional flow o
Styles APA, Harvard, Vancouver, ISO, etc.
8

Su, Nai-Wen, and Yu-Jen Chen. "Metronomic Therapy in Oral Squamous Cell Carcinoma." Journal of Clinical Medicine 10, no. 13 (2021): 2818. http://dx.doi.org/10.3390/jcm10132818.

Texte intégral
Résumé :
Metronomic therapy is characterized by drug administration in a low-dose, repeated, and regular manner without prolonged drug-free interval. The two main anticancer mechanisms of metronomic therapy are antiangiogenesis and immunomodulation, which have been demonstrated in several delicate in vitro and in vivo experiments. In contrast to the traditional maximum tolerated dose (MTD) dosing of chemotherapy, metronomic therapy possesses comparative efficacy but greatlydecreases the incidence and severity of treatment side-effects. Clinical trials of metronomic anticancer treatment have revealed pr
Styles APA, Harvard, Vancouver, ISO, etc.
9

Zhang, Mu, Chen Chen, Feng Su, Zhiguo Huang, Xiangmin Li та Xiaogang Li. "Knockdown of Hypoxia-Inducible Factor 1α Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts". Technology in Cancer Research & Treatment 16, № 5 (2016): 609–19. http://dx.doi.org/10.1177/1533034616665720.

Texte intégral
Résumé :
Low-dose metronomic chemotherapy represents a new strategy for solid tumor treatments with a strong antiangiogenic activity and few side effects. However, low-dose metronomic therapy alone is not always as effective as traditional chemotherapy on eradication of tumor. On the contrary, low-dose metronomic in some cases could stimulate tumor growth due to hypoxia of tumor cells induced during therapy. Our study aimed to investigate whether knockdown of hypoxia-inducible factor-1α expression in tumor cell could facilitate low-dose metronomic therapy with paclitaxel for human colon cancer. Human c
Styles APA, Harvard, Vancouver, ISO, etc.
10

Sun, Xiaofei, Zijun Zhen, Ying Guo, et al. "Oral Metronomic Maintenance Therapy Can Improve Survival in High-Risk Neuroblastoma Patients Not Treated with ASCT or Anti-GD2 Antibodies." Cancers 13, no. 14 (2021): 3494. http://dx.doi.org/10.3390/cancers13143494.

Texte intégral
Résumé :
Despite aggressive treatment, the prognosis of high-risk NB patients is still poor. This retrospective study investigated the benefits of metronomic maintenance treatment (MT) in high-risk NB patients without ASCT or GD2 antibody therapy. Patients aged ≤ 21 years with newly diagnosed high-risk NB were included. Patients with complete/very good partial remission (CR/VGPR/PR) to conventional treatment received, or not, oral metronomic MT for 1 year. Two hundred and seventeen high-risk NB patients were enrolled. One hundred and eighty-five (85%) had a CR/VGPR/PR to conventional treatment, of the
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Thèses sur le sujet "Metronomica"

1

SCAGLIOTTI, ARIANNA. "Analyzing the impact of metronomic scheduling and dosing of 5-Fluorouracil and Vinorelbine in triple-negative breast cancer and endothelial cells." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2021. http://hdl.handle.net/10281/304796.

Texte intégral
Résumé :
Il tumore alla mammella triplo-negativo (TNBC) rappresenta il sottotipo di tumore alla mammella più aggressivo ed è spesso associato ad una breve sopravvivenza libera da malattia. La dose massima tollerata, utilizzata come terapia standard (STD), rimane la prima opzione terapeutica per pazienti con TNBC, anche se non è sufficiente nel bloccare le recidive, le quali rimangono la prima causa di morte per questo tipo di tumore. Recentemente, è stato testato un diverso approccio terapeutico, chiamato chemioterapia metronomica (mCHT), che prevede la continua somministrazione della minima dose biolo
Styles APA, Harvard, Vancouver, ISO, etc.
2

Murray, Alexandra M. "Novel anti-endothelial therapeutic strategies in malignant melanoma : the metronomic approach." Thesis, University of Hull, 2011. http://hydra.hull.ac.uk/resources/hull:5288.

Texte intégral
Résumé :
Treatment strategies for advanced malignancy remain limited in their success, despite major advances in the understanding of cancer aetiology and molecular biology. The incidence of many cancers, including melanoma, continues to rise, with a huge demand for therapies even if treatment goals are purely cytostatic. One particular therapeutic strategy is the metronomic (continuous and low) dosing of conventional chemotherapy. There is evidence to suggest that tumour vasculature is the main target of this dosing schedule resulting in an overall 'non specific' anti-angiogenic effect. It is now bein
Styles APA, Harvard, Vancouver, ISO, etc.
3

Bonus, Alexander Evan. "The Metronomic Performance Practice: A History of Rhythm, Metronomes, and the Mechanization of Musicality." Case Western Reserve University School of Graduate Studies / OhioLINK, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=case1270221548.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Kubisch, Rebekka. "Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug." Diss., Ludwig-Maximilians-Universität München, 2013. http://nbn-resolving.de/urn:nbn:de:bvb:19-158654.

Texte intégral
Résumé :
In the present study the mechanisms leading to acquired chemoresistance, as well as new treatment strategies implying the prevention evading of tumor cells were addressed. Resistance formation is one of the major hurdles in cancer therapy. Metronomic antiangiogenic treatment of xenografted prostate cancer tumors in mice with cyclophosphamide (CPA) results in the appearance of resistant tumors. To investigate the complex molecular changes occurring during resistance formation, a comprehensive gene expression analysis of the resistant tumors in vivo was performed. A multitude of differenti
Styles APA, Harvard, Vancouver, ISO, etc.
5

Mendes, Analy Ramos [UNESP]. "Avaliação da quimioterapia metronômica em carcinomas mamários de cadelas por imunomarcações." Universidade Estadual Paulista (UNESP), 2014. http://hdl.handle.net/11449/128087.

Texte intégral
Résumé :
Made available in DSpace on 2015-10-06T13:03:14Z (GMT). No. of bitstreams: 0 Previous issue date: 2014-08-15. Added 1 bitstream(s) on 2015-10-06T13:18:49Z : No. of bitstreams: 1 000848999.pdf: 1544826 bytes, checksum: 3fb73afedffc7650ac4620d6a79c29e9 (MD5)<br>Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)<br>The canine mammary tumor (CMT) is the neoplasia that most commonly affects not spayed bitches. Therapy for CMT is a challenge since there are not described effective treatments for high-grade tumors. A therapeutic option that slows down tumor angiogenesis is metronomic c
Styles APA, Harvard, Vancouver, ISO, etc.
6

Mendes, Analy Ramos. "Avaliação da quimioterapia metronômica em carcinomas mamários de cadelas por imunomarcações /." Araçatuba, 2014. http://hdl.handle.net/11449/128087.

Texte intégral
Résumé :
Resumo:A neoplasia mamária canina (NMC) é o tipo de neoplasia que mais comumente afeta cadelas não castradas. A terapia para a NMC é um desafio já que não são descritos tratamentos efetivos para neoplasias de alto grau histológico. Uma possibilidade terapêutica que age diminuindo a angiogênese tumoral é a quimioterapia metronômica (QM). Tem sido proposta a quantificação da angiogênese tumoral através da mensuração do fator de crescimento endotelial vascular (VEGF) e da densidade microvascular (DMV). Desta forma, neste estudo, foi avaliada a resposta de carcinomas mamários caninos à QM por mens
Styles APA, Harvard, Vancouver, ISO, etc.
7

Lam, Thomas B. L. "Development of a novel anti-endothelial therapeutic strategy combining metronomic chemotherapy dosing with VRGFR-2 inhibition." Thesis, University of Hull, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.421989.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Sá, Ana Isabel da Silva. "Avaliação dos efeitos secundários induzidos pela administração oral de ciclofosfamida em regime de quimioterapia metronómica em cães e gatos : estudo retrospetivo de 36 casos." Master's thesis, Universidade de Lisboa, Faculdade de Medicina Veterinária, 2016. http://hdl.handle.net/10400.5/12006.

Texte intégral
Résumé :
Dissertação de Mestrado Integrado em Medicina Veterinária<br>A quimioterapia metronómica (QM) consiste na administração de baixas doses de compostos citotóxicos, de forma contínua, sem pausa, por um longo período de tempo. O fármaco citostático mais utilizado em QM é a ciclofosfamida (CIC). Este estudo teve como objetivo avaliar os efeitos adversos induzidos pela QM com CIC, administrada por via oral, em cães e gatos, diagnosticados com neoplasias malignas, através da caracterização dos efeitos secundários manifestados. Incluiram-se todos os cães e gatos, machos e fêmeas, submetidos a tratamen
Styles APA, Harvard, Vancouver, ISO, etc.
9

Marighetti, P. "RESIDUAL DORMANT CANCER STEM CELL FOCI ARE RESPONSIBLE FOR TUMOR RELAPSE AFTER ANGIOGENIC METRONOMIC THERAPY IN HEPATOCELLULAR CARCINOMA XENOGRAFTS." Doctoral thesis, Università degli Studi di Milano, 2012. http://hdl.handle.net/2434/169919.

Texte intégral
Résumé :
Hepatocellular carcinoma (HCC) is the fifth most common solid tumor and the third leading cause of cancer-related death. Current available chemotherapeutic options are not curative due in part to their resistance to conventional therapies. We have generated orthotopic HCC mouse models in immunodeficient NOD/SCID/IL2rγ null mice by injection of AFP- and/or luciferase-expressing HCC cell lines and primary cells from patients, where tumor growth and spread can be accurately monitored in a non-invasive way. Low dose metronomic administration of cyclophosphamide (LDM-CTX) causes in this model comp
Styles APA, Harvard, Vancouver, ISO, etc.
10

Nim, Rasmus. "Upplevelser av en mobiltelefonapplikations metronoma ljudstimulans under anaeroba intervaller : En experimentell studie med elitfriidrottare." Thesis, Karlstads universitet, Handelshögskolan, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-39176.

Texte intégral
Résumé :
Syfte: Syftet med denna kandidatuppsats är att förklara de positiva och negativa aspekter elit-friidrottare upplever av mobiltelefonens metronoma ljudstimulans påverkan under anaeroba intervaller, för en eventuell vidareutveckling.Metod: En applikation med grundläggande funktionalitet, som kunde användas vid testtillfället, utvecklades. 8 stycken elitfriidrottare som vid testtillfället hade topp 20 bästa resultat i sin gren, och ålder, i Sverige genomförde 6 anaeroba intervaller utifrån deras eget träningsprogram. Varannan intervall fick de hjälp av mobiltelefonapplikationen och varannan fick
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Livres sur le sujet "Metronomica"

1

Bocci, Guido, and Giulio Francia, eds. Metronomic Chemotherapy. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43604-2.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Young, Michael Dunlop. The metronomic society: Natural rhythms and human timetables. Thames and Hudson, 1988.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Young, Michael Dunlop. The metronomic society: Natural rhythms and human timetables. Harvard University Press, 1988.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Mir, Manzoor Ahmad. Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment. CRC Press, 2024. http://dx.doi.org/10.1201/9781032632674.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Lebesgue, Henri. La Medida De Las Magnitudes / The Measurement of the Magnitudes (Metronomica / Metronomic). Editorial Limusa S.A. De C.V., 1995.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Young, Michael. The Metronomic Society. Harvard University Press, 1988.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Bocci, Guido, and Giulio Francia, eds. Clinical Applications of Metronomic Chemotherapy. MDPI, 2023. http://dx.doi.org/10.3390/books978-3-0365-9281-7.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Pod stuk metronoma. Peterburgskiĭ i︠u︡ridicheskiĭ in-t MVD Rossii, 2007.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Bocci, Guido, and Giulio Francia. Metronomic Chemotherapy: Pharmacology and Clinical Applications. Springer Berlin / Heidelberg, 2016.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Bocci, Guido, and Giulio Francia. Metronomic Chemotherapy: Pharmacology and Clinical Applications. Springer, 2014.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Chapitres de livres sur le sujet "Metronomica"

1

Mir, Manzoor Ahmad, Asma Jan, Aisha Shabir, and Nusrat Jan. "Metronomics." In Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment. CRC Press, 2024. http://dx.doi.org/10.1201/9781032632674-8.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Kerbel, Robert S. "Development and Evolution of the Concept of Metronomic Chemotherapy: A Personal Perspective." In Metronomic Chemotherapy. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43604-2_1.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Kong, Doo-Sik, and Do-Hyun Nam. "Clinical Activity of Metronomic Chemotherapy in Central Nervous System Cancers." In Metronomic Chemotherapy. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43604-2_10.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Baluch, Narges, Sushil Kumar, Reza Mokhtari, and Sylvain Baruchel. "Metronomic Chemotherapy in Pediatric Malignancies." In Metronomic Chemotherapy. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43604-2_11.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Praditsuktavorn, Pannee, and Jia Ruan. "Metronomic Chemotherapy in Hematological Malignancies." In Metronomic Chemotherapy. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43604-2_12.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Shao, Yu-Yun, Ann-Lii Cheng, and Chih-Hung Hsu. "Clinical Activity of Metronomic Chemotherapy in Liver Cancers." In Metronomic Chemotherapy. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43604-2_13.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Forte, Victoria A., and Agustin A. Garcia. "Metronomic Chemotherapy in Gynecological Cancers." In Metronomic Chemotherapy. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43604-2_14.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Kotsakis, Athanasios, Nikolaos Kentepozidis, and Vassilis Georgoulias. "Metronomic Chemotherapy in Non-Small-Cell Lung Cancer." In Metronomic Chemotherapy. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43604-2_15.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Bocci, Guido, and Giulio Francia. "Pharmacokinetics and Pharmacogenetics of Metronomic Chemotherapy." In Metronomic Chemotherapy. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43604-2_16.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Snihur, Yuliya, Eddy Pasquier, Graciela Scharovsky, and Nicolas Andre. "Metronomics: Potential Social Impact and New Business Models to Improve Availability of Cancer Treatments." In Metronomic Chemotherapy. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43604-2_17.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.

Actes de conférences sur le sujet "Metronomica"

1

Gorinskiy, Vitaliy Ivanovich, and Vladimir Vasilyevich Salautin. "ADJUVANT COMBINED SYSTEMIC THERAPY WITH FIROCOXIB AND CYCLOPHOSPHAMIDE FOR VASCULAR SOFT TISSUE SARCOMAS IN UNPRODUCTIVE DOMESTIC ANIMALS." In Themed collection of papers from Foreign international scientific conference «Joint innovation - joint development». by HNRI «National development» in cooperation with PS of UA. March 2025. - Harbin (China). Crossref, 2025. https://doi.org/10.37539/250327.2025.33.39.010.

Texte intégral
Résumé :
The results of combined systemic therapy with firocoxib and cyclophosphamide in metronomic mode for vascular soft tissue sarcomas in domestic animals are presented. According to the results of therapy, the recurrence-free period averaged ≈ 385 days (min. 152 days, max. 810 days). There were no signs of hematological toxicity. General grade I toxicity was detected in two animals.
Styles APA, Harvard, Vancouver, ISO, etc.
2

Cho, Youngseok, Seung Woo Chung, and Youngro Byun. "Abstract 2676: Radiotherapy-assisted tumor selective metronomic oral chemotherapy." In Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.am2018-2676.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Mazzucchelli, Serena, Marta Truff, Michela Bellini, Maria A. Rizzuto, Davide Prosperi, and Fabio Corsi. "Metronomic Nanocaged Doxorubicin Prevents Chemoresistance and Cardiotoxicity in Breast Cancer." In The 2nd World Congress on Recent Advances in Nanotechnology. Avestia Publishing, 2017. http://dx.doi.org/10.11159/nddte17.123.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Waxman, David J., Chong-Sheng Chen, Junjie Wu, and Joshua C. Doloff. "Abstract A87: Metronomic chemotherapy activates innate immunity-induced tumor regression." In Abstracts: AACR Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances; December 2-5, 2012; Miami, FL. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tumimm2012-a87.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Chalasani, Pavani, Livingston B. Robert, Thomas A. Rado, et al. "Abstract OT2-2-05: Metronomic eribulin in metastatic breast cancer." In Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 9-13, 2014; San Antonio, TX. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.sabcs14-ot2-2-05.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Peceli, Balint, Daniel Andras Drexler, and Levente Kovacs. "Optimal scheduling of low-dose metronomic chemotherapy: an in-silico analysis." In 2020 IEEE 15th International Conference of System of Systems Engineering (SoSE). IEEE, 2020. http://dx.doi.org/10.1109/sose50414.2020.9130500.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Wilson, Brian C., Stuart K. Bisland, Arjen Bogaards, et al. "Metronomic photodynamic therapy (mPDT): concepts and technical feasibility in brain tumor." In Biomedical Optics 2003, edited by David Kessel. SPIE, 2003. http://dx.doi.org/10.1117/12.479435.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Tsai, Kelvin K., and Tze-sian Chan. "Abstract A19: Metronomic chemotherapy enhances immunotherapy by preventing stroma-induced immunosuppression." In Abstracts: AACR Special Conference on Tumor Immunology and Immunotherapy; November 27-30, 2018; Miami Beach, FL. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/2326-6074.tumimm18-a19.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Ciccolini, Joseph, Eddy Pasquier, Aurelie Lombard, et al. "Abstract 4506: Computational-driven metronomics: application to gemcitabine in neuroblastoma-bearing mice." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-4506.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Bisland, Stuart, Lothar Lilge, Annie Lin, and Brian C. Wilson. "Metronomic Photodynamic Therapy (mPDT) for Intracranial Neoplasm: Physiological, Biological and dosimetry considerations." In European Conference on Biomedical Optics. OSA, 2003. http://dx.doi.org/10.1364/ecbo.2003.5142_9.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.

Rapports d'organisations sur le sujet "Metronomica"

1

Xie, Ying, Xinjie Chen, and XiaoMin Wang. Efficacy evaluation of metronomic chemotherapy for breast cancer: a network meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.4.0142.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Ferrone, Soldano. Combinational Targeting of Prostate Carcinoma Cells and Tumors Associated Pericytes with Antibody Based Immunotherapy and Metronomic Chemotherapy. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada529444.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Ferrone, Soldano. Combinational Targeting of Prostate Carcinoma Cells and Tumors Associated Pericytes with Antibody Based Immunotherapy and Metronomic Chemotherapy. Defense Technical Information Center, 2009. http://dx.doi.org/10.21236/ada551782.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Ferrone, Soldano, Barbara Foster, and Michael Moser. Combinatorial Targeting of Prostate Carcinoma Cells and Tumor Associated Pericytes with Antibody-Based Immunotherapy and Metronomic Chemotherapy. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada551786.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Ferrone, Soldano, Barbara Foster, and Michael Moser. Combinational Targeting of Prostate Carcinoma Cells and Tumors Associated Pericytes with Antibody Based Immunotherapy and Metronomic Chemotherapy. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada482376.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Chen, Xiaoyuan. Alpha-v Integrin Targeted PET Imaging of Breast Cancer Angiogenesis and Low-Dose Metronomic Anti-Angiogenic Chemotherapy Efficacy. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada588970.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Chen, Xiaoyuan. Alpha-v Integrin Targeted PET Imaging of Breast Cancer Angiogenesis and Low-Dose Metronomic Anti-Angiogenic Chemotherapy Efficacy. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada469375.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Chen, Xiaoyuan. Alpha-v Integrin Targeted PET Imaging of Breast Cancer Angiogenesis and Low-Dose Metronomic Anti-Angiogenic Chemotherapy Efficacy. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada476052.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Vous pouvez également être intéressé par les bibliographies sur le sujet « Metronomica » pour d’autres types de sources :
Articles de revues Thèses Livres
Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!

Vers la bibliographie